Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasodilators in mechanical ventilation

J L Zimmerman1, N A Hanania

  • 1Baylor College of Medicine, Houston, Texas, USA.

Critical Care Clinics
|January 19, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences and determinants of anxiety symptoms in patients with COPD initiating pulmonary rehabilitation.

Respiratory medicine·2024
Same author

Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma.

Allergy·2017
Same author

Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2016
Same author

New perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma.

British journal of pharmacology·2010
Same author

Separating couples from restraining patterns and the relationship discourse that supports them*.

Journal of marital and family therapy·2010
Same author

Response to salbutamol in patients with mild asthma treated with nadolol.

The European respiratory journal·2010
Same journal

Critical Care and Contagion: Evolving Frontiers of Infectious Diseases in the Modern Intensive Care Unit.

Critical care clinics·2026
Same journal

Advances and Challenges in Sepsis Care in Low-Resource Settings.

Critical care clinics·2026
Same journal

The Respiratory Triple Pandemic in the Intensive Care Unit: Epidemiology, Clinical Features and Management of COVID-19, Influenza and Respiratory Syncytial Virus.

Critical care clinics·2026
Same journal

Antibiotic Stewardship for the Intensivist.

Critical care clinics·2026
Same journal

Infection Prevention and Control in the Intensive Care Unit.

Critical care clinics·2026
Same journal

Antibiotic Considerations in the Critically Ill: Empiric Choices and Dosing.

Critical care clinics·2026
See all related articles

Pulmonary vasodilators like inhaled nitric oxide and aerosolized prostacyclin may improve oxygenation in ventilated patients but have not yet shown improved clinical outcomes. Their use in critical care remains investigational.

Area of Science:

  • Cardiopulmonary medicine
  • Pharmacology

Background:

  • Pulmonary vasodilators are useful in mechanical ventilation for conditions like ARDS, COPD, and PPHN.
  • Systemic side effects of parenteral vasodilators limit their use in critically ill patients.
  • Inhaled vasodilators offer targeted pulmonary effects with fewer systemic issues.

Purpose of the Study:

  • To review the efficacy and clinical outcomes of pulmonary vasodilators in mechanically ventilated patients.
  • To compare the systemic versus selective pulmonary effects of various vasodilator agents.

Main Methods:

  • Review of existing literature on pulmonary vasodilators in mechanical ventilation.
  • Analysis of physiological effects, including pulmonary artery pressure (PAP) and oxygenation.
  • Evaluation of clinical outcomes associated with vasodilator use.

Related Experiment Videos

Main Results:

  • Inhaled nitric oxide and aerosolized prostacyclin selectively reduce PAP and improve oxygenation.
  • Liposomal PGE1 shows limited systemic effects but no significant clinical benefit in ARDS.
  • Despite physiological improvements, inhaled NO and aerosolized prostacyclin have not demonstrated improved clinical outcomes.

Conclusions:

  • Current use of pulmonary vasodilators in mechanically ventilated patients is investigational.
  • Further research is needed to establish clear clinical benefits and optimal use of these agents.
  • Balancing pulmonary vasodilation with systemic effects remains a key challenge.